Chemical Component Summary

NameN-(4-HYDROXYPHENYL)ALL-TRANS RETINAMIDE
Identifiers(2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenamide
FormulaC26 H33 N O2
Molecular Weight391.55
TypeNON-POLYMER
Isomeric SMILESCC1=C(\C=C\C(C)=C\C=C\C(C)=C\C(=O)Nc2ccc(O)cc2)C(C)(C)CCC1
InChIInChI=1S/C26H33NO2/c1-19(11-16-24-21(3)10-7-17-26(24,4)5)8-6-9-20(2)18-25(29)27-22-12-14-23(28)15-13-22/h6,8-9,11-16,18,28H,7,10,17H2,1-5H3,(H,27,29)/b9-6+,16-11+,19-8+,20-18+
InChIKeyAKJHMTWEGVYYSE-FXILSDISSA-N

Chemical Details

Formal Charge0
Atom Count62
Chiral Atom Count0
Bond Count63
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB05076 
NameFenretinide
Groupsinvestigational
DescriptionA synthetic retinoid that is used orally as a chemopreventive against prostate cancer and in women at risk of developing contralateral breast cancer. It is also effective as an antineoplastic agent.
Synonyms
  • 4-HPR
  • N-(4-hydroxyphenyl)all-trans retinamide
  • 4-hydroxyphenyl retinamide
  • 4-hydroxy(phenyl)retinamide
  • Fenretinide
IndicationInvestigated for use/treatment in macular degeneration.
Categories
  • Alkenes
  • Anticarcinogenic Agents
  • Antineoplastic Agents
  • Biological Factors
  • Carotenoids
CAS number65646-68-6

Drug Targets

NameTarget SequencePharmacological ActionActions
Retinol-binding protein 4MKWVWALLLLAALGSGRAERDCRVSSFRVKENFDKARFSGTWYAMAKKDP...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem5288209
ChEBICHEBI:42588
ChEBICHEBI:92493
ChEMBLCHEMBL7301
PharosCHEMBL7301